InvestorsHub Logo

Flyfish 1

03/24/14 3:42 PM

#7642 RE: RobinIV #7641

I think formulation is NRTI's side of the deal. Once extracted, the oil can be used directly of blended into nutritional products. I'm surprised that the stock is down. I think that this equipment purchase means the supplements are closer than ever. Remember, that our CEO is a TRTC Director. If the equipment was simply a duplication, there would be no need to purchase it. Go NRTI.

goldmansack

03/24/14 3:46 PM

#7644 RE: RobinIV #7641

Formulation is what NRTI is probably most concerned with considering the CBD team they've assembled. By having trtc control growth and extraction they give nrti the ability to formulate various supplements with various formulas that will be used to treat multiple specific medical issues that differ from each other, such as epilepsy, MS, and lupus. Think of nrti as the pharmaceutical company in this partnership. Trtc is the grower of different strains that will supply nrti with compounds of various levels of CBD that they can then formulate to treat a vast array of medical conditions. I see the partnership producing several different kinds of CBD supplements, not just one.